## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T08:37:13.756Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "PMcardio for Individuals" developer_entity: "Powerful Medical" bundle_id: "com.powerfulmedical.pmcardio" app_store_id: "1640037895" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-05-18" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "3.11.3" total_reviews: 803 overall_rating: 4.25 sentiment: "Frustrated" sentiment_score: 35 confidence: "low" confidence_score: 0.8 top_praise_theme: "Advanced AI diagnostic capabilities provide actionable insights for medical professionals during clinical practice" top_complaint_theme: "Geographic access restrictions prevent users in specific regions from utilizing the diagnostic service" top_request_theme: "Institutional licensing options would allow hospitals to integrate the diagnostic tool into existing systems" review_sample_size: 73 total_review_count: 73 analyzed_review_count: 60 data_age_days: 0 momentum_velocity: "active" intelligence_version: 3 nemesis: "Kardia" competitor_count: 6 tags: ["medical", "freemium", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "including"] canonical_url: "https://marlvel.ai/intel-report/medical/com-powerfulmedical-pmcardio" license: "CC-BY-NC 4.0" content_version: "v2" --- # PMcardio for Individuals App Audit ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.25 · Sentiment Frustrated - **Recent focus**: Geographic access restrictions prevent users in specific regions from utilizing the diagnostic service (top complaint) · Advanced AI diagnostic capabilities provide actionable insights for medical professionals during clinical practice (top praise) · Institutional licensing options would allow hospitals to integrate the diagnostic tool into existing systems (top request) > **TL;DR:** PMcardio for Individuals is a medical app by Powerful Medical, rated 4.25/5 by 803 users, with Frustrated user sentiment (35/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** PMcardio for Individuals faces Frustrated user sentiment (4.25/5 from 803 reviews), with geographic access restrictions prevent users in specific regions from utilizing the diagnostic service as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.25/5 (803 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Powerful Medical | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Low (0.8/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Powerful Medical - **Category:** Medical - **Target Audience:** Healthcare professionals including emergency physicians, general practitioners, nurses, paramedics, and cardiologists. - **Platforms:** iOS & Android - **Version Audited:** 3.11.3 - **Audit Date:** 2026-05-20 - **Signal Count:** 73 reviews analyzed - **Confidence:** Low (0.8/1.0) - **App Store ID (iOS):** 1640037895 - **Bundle ID:** com.powerfulmedical.pmcardio - **Google Play ID:** com.powerfulmedical.pmcardio - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** AI that reads ECGs ## Executive Snapshot **What it is:** PMcardio is a mobile AI assistant for 12-lead ECG interpretation, designed for healthcare professionals to use on iOS and Android. **Why users hire it:** Clinicians hire the app for rapid, automated diagnostic support on ECG images, serving as a second opinion in high-pressure emergency workflows. ## App DNA (Features & Intent) - **[Differentiator] Queen of Hearts AI Model:** Deep learning model for detecting STEMI and occlusive myocardial infarction patterns. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Differentiator] ECGxplain Heatmaps:** Visual heatmaps highlighting waveform segments that triggered specific AI diagnostic outputs. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Automated ECG Measurements:** Instant calculation of 12 clinical metrics including heart rate and intervals. ## Market Position {#market-position} PMcardio holds a #6 Grossing position in the Medical category across 20+ international markets, but its #18 Grossing rank in the US signals significant friction in the largest professional market. The gap between its diagnostic utility and regional availability limits its ability to capture the full addressable market. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free plan with 5 ECG analyses per month, Pro plan with unlimited capacity and advanced explainability - **Analysis:** The freemium model uses a low-volume free tier to drive acquisition, with a Pro subscription gate for high-frequency professional workflows. ## 🔴 User Sentiment (Low Confidence: 60 of 73 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.25/5 - **Platform Split:** iOS 4.4/5 (248 ratings) | Android 4.2/5 (555 ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.25/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Advanced AI diagnostic capabilities provide actionable insights for medical professionals during clinical practice** ### Top Complaints (Impact Areas) - **Geographic access restrictions prevent users in specific regions from utilizing the diagnostic service** ### Top Requests (What Users Want) - **Institutional licensing options would allow hospitals to integrate the diagnostic tool into existing systems** ## SWOT Analysis {#swot} **Core Strengths:** - Clinical-grade diagnostic capability functions as a B2B distribution barrier - 19 independent validation studies provide the clinical evidence required for professional adoption **Critical Frictions:** - Regional lockout errors block users without warning - Inconsistent diagnostic accuracy reports erode trust in the AI model **Growth Levers:** - Institutional enterprise licensing would allow hospitals to integrate the tool into existing clinical systems - Expansion into resource-limited markets via tiered pricing **Market Threats:** - Kardia's hardware-backed diagnostic ecosystem creates a high switching cost - Regulatory tightening in the EU and UK limits the addressable market for new AI modules ## Recent Changes (v2 → v3) {#recent-changes} PMcardio is pivoting toward enterprise-grade clinical utility to counter declining sentiment and regional access friction. **Overall trend**: Mixed **Compared at**: 2026-05-20 ### High-impact changes - **[Declined] Rating and Sentiment Friction** (sentiment) — App rating decreased from 4.58 to 4.17, with new complaints regarding geographic access restrictions blocking users. - **[Shifted] Enterprise-Focused Roadmap** (positioning) — Strategic focus moved from individual subscription growth to institutional enterprise licensing to bypass consumer-level friction. ### Medium-impact changes - **[Added] Clinical Diagnostic Modules** (features) — Added LVsense ejection fraction module and clinical calculators (SCORE2, SCORE2-Diabetes, SCORE2-OP). - **[Added] Clinical Validation and Regulatory Threats** (swot) — Added 19 independent validation studies as a strength; added EU/UK regulatory tightening as a new threat. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### PMcardio for Individuals vs Kardia — Head to Head - **[Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: Kardia is the dominant market leader in ECG interpretation, leveraging a massive user base and deep integration with hardware-backed diagnostic workflows. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Integrates directly with proprietary mobile ECG hardware to provide clinical-grade diagnostic data for users. - Offers a closed-loop ecosystem connecting patient-recorded ECGs directly to physician review platforms. - Maintains a high-frequency release cadence, shipping 7 updates in the last six months to ensure stability. - **Where PMcardio for Individuals wins:** - ✅ Focuses on AI-powered interpretation of existing ECG images rather than requiring proprietary hardware peripheral ownership. - ✅ Provides a more streamlined, pocket-based diagnostic assistant for emergency and general practitioners. - **Where Kardia wins:** - ❌ Leverages a massive, established network effect between patient-side hardware and professional-side diagnostic review tools. - ❌ Offers a more comprehensive clinical workflow that bridges the gap between home monitoring and professional cardiology. - **Verdict:** The target app must differentiate by emphasizing its software-only, image-agnostic AI utility to avoid the hardware-dependency barrier that Kardia has successfully institutionalized. ### Contenders (Strong Challengers) - **[Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10)** by Doximity [Moat: High]: Doximity serves as the primary professional network for physicians, creating a massive barrier to entry for any clinical tool. - Functions as a comprehensive professional directory and communication hub for the entire US medical community. - Aggregates clinical news and career resources, creating a daily-use habit that PMcardio lacks. - **[PulsePoint Respond](https://marlvel.ai/intel-report/medical/org-pulsepoint-pulsepoint)** by PulsePoint Foundation [Moat: Medium]: PulsePoint dominates the emergency response niche by connecting bystanders to cardiac events in real-time. - Integrates with local emergency dispatch systems to alert nearby CPR-trained citizens to cardiac arrests. - Provides a public-safety utility that creates high brand trust and massive user engagement in emergency scenarios. ### Peers (What They Do Better) - **[Complete Anatomy for iPhone](https://marlvel.ai/intel-report/medical/com-3d4medical-caphone)** by 3D4Medical from Elsevier: An adjacent medical education tool that competes for the same professional screen time as PMcardio. - Utilizes high-fidelity 3D anatomical modeling to assist in patient education and surgical planning. - Offers a subscription-based model that provides deep, interactive visual content for medical students and professionals. - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr)** by mySugr GmbH: A specialized chronic disease management tool that competes for the attention of healthcare-focused users. - Provides a gamified, data-driven logging experience specifically tailored for long-term diabetes management and patient compliance. - Integrates with blood glucose monitors to automate data entry, reducing the manual burden on the user. ### New Kids on the Block (What's Innovative) - **[ShiftKey - PRN Healthcare Jobs](https://marlvel.ai/intel-report/medical/com-shiftkey-provider)** by ShiftKey, LLC: Rapidly emerging in the healthcare space with a high-velocity release schedule and strong focus on workforce utility. ## What's New - **Latest (v3.11.3, 2 days ago):** Added SCORE2, SCORE2-Diabetes, and SCORE2-OP calculators to report details and improved Queen of Hearts score precision. ## App Momentum (Active) {#momentum} - Launched LVsense ejection fraction module. - Added clinical calculators for SCORE2. - Improved Queen of Hearts score precision. > **Cadence:** 5 total versions · 4 majors in last 6 months · 2 days since last update · 14 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} PMcardio for Individuals is a challenged medical app that is free with in-app purchases. With a 4.25/5 rating from 803 reviews, it faces significant user friction. > **Bottom Line:** PMcardio wins on clinical-grade diagnostic utility, but regional access failures and inconsistent AI outputs threaten its professional retention, so the PM must prioritize enterprise licensing to bypass individual subscription friction. **Best for:** Healthcare professionals including emergency physicians, general practitioners, nurses, paramedics, and cardiologists. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Audit regional lockout messaging because users report being blocked without warning → reduce churn. — *Geographic access restrictions are the top-cited complaint in sentiment analysis.* _(trade-off: deprioritize Pause the LVsense module marketing rollout — fixing the funnel is more critical than new feature awareness.)_ - [ ] [INVEST] [HIGH IMPACT] Ship enterprise licensing portal because institutional requests are the primary growth signal → unlock hospital-wide adoption. — *Institutional licensing is the top-requested feature by professional users.* _(trade-off: deprioritize Deprioritize the consumer-facing UI refresh — enterprise revenue has a higher lifetime value per user.)_ ### Feature Gaps vs Competitors - Direct integration with proprietary mobile ECG hardware (available in Kardia but missing here) ### Outlook: Declining The diagnostic AI market is consolidating around integrated clinical workflows, leaving PMcardio exposed if it cannot resolve regional access friction. The current reliance on individual subscriptions is failing to scale, so the PM must pivot to institutional licensing to secure long-term revenue stability. - 🔴 Geographic access errors in the latest update drive high churn, which compounds the negative sentiment already visible in professional reviews. - 🟢 The launch of the LVsense module demonstrates active feature investment, signaling the team is not in maintenance mode despite sentiment headwinds. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.25/5 | | Total Reviews | 803 | | Sentiment | Frustrated (35/100) | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **PMcardio for Individuals** (this app) | 4.25/5 | Frustrated | Powerful Medical | | [Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) | 4.8/5 | N/A | Doximity | | [Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. | | [ShiftKey - PRN Healthcare Jobs](https://marlvel.ai/intel-report/medical/com-shiftkey-provider) | 4.7/5 | N/A | ShiftKey, LLC | | [PulsePoint Respond](https://marlvel.ai/intel-report/medical/org-pulsepoint-pulsepoint) | 4.8/5 | N/A | PulsePoint Foundation | | [Complete Anatomy for iPhone](https://marlvel.ai/intel-report/medical/com-3d4medical-caphone) | 4.5/5 | Frustrated | 3D4Medical from Elsevier | ## Company Profile - **Developer:** Powerful Medical - **Website:** [https://www.powerfulmedical.com/](https://www.powerfulmedical.com/) - **Social:** [Instagram](https://www.instagram.com/powerfulmedical) · [Facebook](https://www.facebook.com/powerfulmedical) · [X/Twitter](https://twitter.com/PowerfulMedical) · [LinkedIn](https://www.linkedin.com/company/powerful-medical) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/pmcardio-for-individuals/id1640037895?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.powerfulmedical.pmcardio&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.powerfulmedical.com/) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Doximity*](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) (Doximity) — 4.8/5 Rating | N/A Sentiment - [*Kardia*](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) (AliveCor, Inc.) — 4.8/5 Rating | N/A Sentiment - [*ShiftKey - PRN Healthcare Jobs*](https://marlvel.ai/intel-report/medical/com-shiftkey-provider) (ShiftKey, LLC) — 4.7/5 Rating | N/A Sentiment - [*PulsePoint Respond*](https://marlvel.ai/intel-report/medical/org-pulsepoint-pulsepoint) (PulsePoint Foundation) — 4.8/5 Rating | N/A Sentiment - [*Complete Anatomy for iPhone*](https://marlvel.ai/intel-report/medical/com-3d4medical-caphone) (3D4Medical from Elsevier) — 4.5/5 Rating | Negative Sentiment - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.8/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 73 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-powerfulmedical-pmcardio) Data licensed for AI Agent attribution under CC-BY-NC 4.0.